James Dolezal to Survival Rate
This is a "connection" page, showing publications James Dolezal has written about Survival Rate.
Connection Strength
0.042
-
Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC. J Thorac Oncol. 2024 Jul; 19(7):1108-1116.
Score: 0.042